Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dilated cardiomyopathy
Robert G. Weintraub, Christopher Semsarian, Peter S. Macdonald
The Lancet (2017) Vol. 390, Iss. 10092, pp. 400-414
Closed Access | Times Cited: 540

Showing 1-25 of 540 citing articles:

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Katja Zeppenfeld, Jacob Tfelt‐Hansen, Marta Riva, et al.
European Heart Journal (2022) Vol. 43, Iss. 40, pp. 3997-4126
Closed Access | Times Cited: 1691
NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
Cheng Zeng, Fengqi Duan, Jia Hu, et al.
Redox Biology (2020) Vol. 34, pp. 101523-101523
Open Access | Times Cited: 267
Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
Cristina Gil‐Cruz, Christian Perez‐Shibayama, Angelina De Martin, et al.
Science (2019) Vol. 366, Iss. 6467, pp. 881-886
Open Access | Times Cited: 226
Dilated cardiomyopathy: from epidemiologic to genetic phenotypes
Daniel Reichart, Christina Magnussen, Tanja Zeller, et al.
Journal of Internal Medicine (2019) Vol. 286, Iss. 4, pp. 362-372
Open Access | Times Cited: 184
Cardiomyopathies: An Overview
Tiziana Ciarambino, Giovanni Menna, G Sansone, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7722-7722
Open Access | Times Cited: 151
The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action
Éloi Marijon, Kumar Narayanan, Karen Smith, et al.
The Lancet (2023) Vol. 402, Iss. 10405, pp. 883-936
Closed Access | Times Cited: 95
Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice
Junying Wang, Wenting Lu, Jerry Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Inherited Arrhythmias in the Pediatric Population: An Updated Overview
Marco Valerio Mariani, Nicola Pierucci, Francesca Fanisio, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 94-94
Open Access | Times Cited: 26
Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies
Gemma Chiva‐Blanch, Lina Badimón
Nutrients (2019) Vol. 12, Iss. 1, pp. 108-108
Open Access | Times Cited: 144
Beyond the One Gene–One Disease Paradigm
Marina Cerrone, Carol Ann Remme, Rafik Tadros, et al.
Circulation (2019) Vol. 140, Iss. 7, pp. 595-610
Open Access | Times Cited: 115
Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy
Xuan Sun, Anqi Shan, Zilun Wei, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 503, Iss. 4, pp. 2611-2618
Closed Access | Times Cited: 114
Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging
Erwan Donal, Victoria Delgado, Chiara Bucciarelli‐Ducci, et al.
European Heart Journal - Cardiovascular Imaging (2019) Vol. 20, Iss. 10, pp. 1075-1093
Open Access | Times Cited: 85
Pyroptosis-Induced Inflammation and Tissue Damage
Yinan Wei, Ling Yang, Ankit Pandeya, et al.
Journal of Molecular Biology (2021) Vol. 434, Iss. 4, pp. 167301-167301
Open Access | Times Cited: 79
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy
Gherardo Finocchiaro, Marco Merlo, Nabeel Sheikh, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 7, pp. 1097-1107
Open Access | Times Cited: 73
T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy
Shuang Li, Di Zhou, Arlene Sirajuddin, et al.
JACC. Cardiovascular imaging (2021) Vol. 15, Iss. 4, pp. 578-590
Open Access | Times Cited: 72
Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay
Leonardo Schirone, Luca D’Ambrosio, Maurizio Forte, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2000-2000
Open Access | Times Cited: 55
Roles and mechanisms of the m6A reader YTHDC1 in biological processes and diseases
Huaqing Yan, Liqi Zhang, Xiaobo Cui, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 46
Heart-on-a-chip platforms and biosensor integration for disease modeling and phenotypic drug screening
Joseph Criscione, Zahra Rezaei, Carol M. Hernandez Cantu, et al.
Biosensors and Bioelectronics (2022) Vol. 220, pp. 114840-114840
Open Access | Times Cited: 46
Modeling Heart Diseases on a Chip: Advantages and Future Opportunities
Omar Mourad, Ryan Yee, Mengyuan Li, et al.
Circulation Research (2023) Vol. 132, Iss. 4, pp. 483-497
Closed Access | Times Cited: 37
Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK/mTOR pathway
Sheng Zhang, Xueping Wei, Haijin Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114691-114691
Open Access | Times Cited: 29
Association Between Shock Etiology and 5-Year Outcomes After Venoarterial Extracorporeal Membrane Oxygenation
Pichoy Danial, Maud-Emmanuel Olivier, Nicolas Bréchot, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 9, pp. 897-909
Open Access | Times Cited: 23
Exploring the Connection Between Relaxed Myosin States and the Anrep Effect
Vasco Sequeira, Christoph Maack, Gert‐Hinrich Reil, et al.
Circulation Research (2024) Vol. 134, Iss. 1, pp. 117-134
Closed Access | Times Cited: 12
Genetic testing in cardiovascular disease
Michael P. Gray, Diane Fatkin, Jodie Ingles, et al.
The Medical Journal of Australia (2024) Vol. 220, Iss. 8, pp. 428-434
Open Access | Times Cited: 11
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy
Pablo García‐Pavía, José F. Rodríguez‐Palomares, Gianfranco Sinagra, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 10
Non‐dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes
Yuko Eda, Takeru Nabeta, Saeko Iikura, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 3, pp. 1463-1471
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top